Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: A cross sectional study Clinical rheumatology and osteoporosis

BMC Musculoskeletal Disorders

Volumn 16, Issue 1, 2015, Pages

  Kumar, Kanta ^a,b,c   Raza, Karim ^a,b   Nightingale, Peter ^d   Horne, Robert ^e   Chapman, Sarah ^e   Greenfield, Sheila ^a   Gill, Paramjit ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adherence; Beliefs about medicines; DMARDs; Ethnicity; Illness representation; Rheumatoid arthritis; Satisfaction with information

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; METHOTREXATE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY; ANTIRHEUMATIC AGENT;

ADULT; ARTICLE; BELIEFS ABOUT MEDICINES QUESTIONNAIRE; BRITISH CITIZEN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE DURATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH BELIEF; HUMAN; ILLNESS PERCEPTIONS QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; MEDICATION ADHERENCE REPORT SCALE; MEDICATION COMPLIANCE; OUTPATIENT; PATIENT SATISFACTION; QUESTIONNAIRE; RATING SCALE; READING; RHEUMATOID ARTHRITIS; SATISFACTION WITH INFORMATION ABOUT MEDICATION SCALE; SOCIAL DETERMINANTS OF HEALTH; SOCIAL STATUS; SOUTH ASIAN; AGED; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; ATTITUDE TO HEALTH; CAUCASIAN; ENGLAND; ETHNOLOGY; MIDDLE AGED; PSYCHOLOGY;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-SECTIONAL STUDIES; ENGLAND; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES;

EID: 84952312717     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/s12891-015-0831-8     Document Type: Article

References (49)

1. Emery P. Treatment of rheumatoid arthritis. BMJ. 2006;332:152-5.
2. Raza K, Buckley CE, Salmon M, Buckley CD. Treating very early rheumatoid arthritis. Clin Rheumatol. 2006;20:849-63.
3. Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M, et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) 2002;41(7):793-800.
4. Hallert E, Husberg M, Kalkan A, Skogh T, Bernfort L. Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project. Scand J Rheumatol 2014;43(3):177-183.
5. National Audit Office Report. Services for people with rheumatoid arthritis. 2009. [accessed 2015 March. 05]; Available from: URL: http://www.nao.org.uk/publications/0809/rheumatoid-arthritis.aspx.
6. World Health Organization. Adherence to long-term therapies. Evidence for action. Geneva: World Health Organization; 2003.
7. Contreras-Yanez I, Ponce De LS, Cabiedes J, Rull-Gabayet M, Pascual-Ramos V. Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs. Am J Med Sci 2010; 340(4):282-290.
8. van den Bemt BJ, Zwikker HE, van den Ende CH. Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Clin Immunol. 2012;8:337-51.
9. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding Patients' Adherence-Related Beliefs about Medicines Prescribed for Long-Term Conditions: A Meta-Analytic Review of the Necessity-Concerns Framework. PLoS One 2013; 8(12):e80633.
10. Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004; 363(9410):675-681.
11. van der Heijde D, Klareskog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J et al. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum 2006; 54(4):1063-1074.
12. Neame R, Hammond A. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology. 2005;44:762-7.
13. Kumar K, Gordon C, Toescu V, Buckley CD, Horn R, Nightingale PG et al. Beliefs about medicines in patients with RA and SLE: a comparison between patients of South Asian and White British origin. Rheumatology 2008;47(5);690-697.
14. Kumar K, Gordon C, Barry R, Shaw K, Horne R, Raza K. 'It's like taking poison to kill poison but I have to get better': a qualitative study of beliefs about medicines in Rheumatoid arthritis and Systemic lupus erythematosus patients of South Asian origin. Lupus 2011; 20(8):837-844.
15. Kumar K, Daley E, Khattak F, Buckley CD, Raza K. The influence of ethnicity on the extent of, and reasons underlying, delay in general practitioner consultation in patients with RA. Rheumatology (Oxford) 2010; 49(5):1005-1012.
16. Kett C, Flint J, Openshaw M, Raza K, Kumar K. Self-management strategies used during flares of rheumatoid arthritis in an ethnically diverse population. Musculoskeletal Care 2010; 8(4):204-214.
17. Horne R, Weinman J. Self regulation and self management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventor medication. Psychol Health. 2002;17:17-32.
18. Cooper V, Gellaitry G, Hankins M, Fisher M, Horne R. The influence of symptom experiences and attributions on adherence to highly active anti-retroviral therapy (HAART): a six-month prospective, follow-up study. AIDS Care. 2009;21:520-8.
19. Goodacre LJ, Goodacre JA. Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication. Rheumatology. 2004;43:583-6.
20. Horne R, Parham R, Driscoll R, Robinson A. Patients' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15(6):837-844.
21. Horne R, Hankins M, Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research. Qual Health Care. 2001;10:135-40.
22. Kumar K, Raza K, Nightingale P, Horne R, Shaw K, Greenfield S et al. A mixed methods protocol to investigate medication adherence in patients with rheumatoid arthritis of White British and South Asian origin. BMJ Open 2013; 3:1-6.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31(3):315-324.
24. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555-67.
25. Hunot VM, Horne R, Leese MN, Churchill RC. A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Prim Care Companion J Clin Psychiatry 2007; 9(2):91-99.
26. Johnson G, Kong CM, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005;3:198-3204.
27. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medicines. Psychol Health. 1999;14:1-24.
28. Weinman J, Petrie KJ. Illness perceptions: a new paradigm for psychosomatics? J Psychosom Res. 1997;42:113-6.
29. Kirwan JR, Reeback JS. Stanford health assessment questionnaire modified to assess disability in British patients with rheumatoid-arthritis. Br J Rheumat. 1986;25:206-9.
30. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993; 36(6):729-740.
31. Koller M, Aaronson NK, Blazeby J, Bottomley A, Dewolf L, Fayers P et al. Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer 2007; 43(12):1810-1820.
32. Payne RA, Abel GA. UK indices of multiple deprivation - a way to make comparisons across constituent countries easier. Health Stat Q. 2013;22-37.
33. Berry D, Bradlow A, Bersellini E. Perceptions of the risks and benefits of medicines in patients with rheumatoid arthritis and other painful musculokeletal conditions. Rheumatology. 2004;43:901-5.
34. Treharne GJ, Lyons AC, Kitas GD. Medication adherence in rheumatoid arthritis: effects of psychosocial factors. Psychol Med. 2004;9:337-49.
35. Helliwell PS, Ibranhim G. Ethnic differences in responses to disease modifying drugs. Rheumatology. 2003;42:1197-201.
36. Horne R, James D, Petrie K, Weinman J, Vincent R. Patients' interpretation of symptoms as a cause of delay in reaching hospital during acute myocardial infarction. Heart 2000; 83(4):388-393.
37. Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res. 2008;64:41-6.
38. Petrie KJ, Cameron LD, Ellis CJ, Buick D, Weinman J. Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med 2002; 64(4):580-586.
39. Fraenkel L, Bogardus S, Concato J, et al. Unwillingness of rheumatoid arthritis patients to risk adverse effects. Rheumatology. 2006;41:253-61.
40. Lip GY, Luscombe C, McCarry M, et al. Ethnic differences in public health awareness, health perceptions and physical exercise: implications for heart disease prevention. Heart. 2004;1:47-53.
41. Lip GY, Khan H, Bhatnagar A, et al. Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project. Heart. 2004;90:1016-9.
42. Lip GY, Kamath S, Jafri M, et al. Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project. Stroke. 2002;33:238-42.
43. Lawton J, Ahmad N, Hallowell N, et al. Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study. BMJ. 2005;330:1247.
44. Lawton J, Ahmad N, Peel E, Hallowell N. Contextualising accounts of illness: notions of responsibility and blame in white and South Asian respondents' accounts of diabetes causation. Sociol Health Illn 2007; 29(6):891-906.
45. Lawton J, Parry O, Peel E, et al. Diabetes service provision: a qualitative study of newly diagnosed Type 2 diabetes patients' experiences and views. Diabet Med. 2005;22:1246-51.
46. Meetoo D. Dietary pattern of self-care among Asian and Caucasian diabetic patients. Br J Nurs. 2004;13:1074-8.
47. Meetoo D, Meetoo L. Explanatory models of diabetes among Asian and Caucasian participants. Br J Nurs 2005; 14(3):154-159.
48. Horne R, Weinman J, Barbar N, Elliot R. Concordance, adherence and compliance in medicine taking. 2005. Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R&D 2005; London, UK.
49. Sanderson T, Hewlett S, Calnan M, Morris M, Raza K, Kumar K. Exploring the cultural validity of rheumatology outcomes. Br J Nurs 2012; 21(17):1015-3.